Medicare billing address
CMS Medicare provider billing file
5445 Lanark Rd Ste 300Center Valley, PA 18034
CMS public data · NPI 1790701092
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Sara Choudhry, M.D
Specialty
Credential
M.D
NPI
1790701092
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Sara Choudhry, M.D from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
5445 Lanark Rd Ste 300CMS Doctors & Clinicians file
100 St Lukes LnCMS Doctors & Clinicians file
100 St Lukes LnCMS Doctors & Clinicians file
100 St Lukes WayIn the 2024 CMS provider billing file, this NPI had 535 Medicare beneficiaries and 14,602 total services. The average beneficiary age was 73, and the average HCC risk score was 1.7.
Total Medicare allowed amount
$316,344.86
Total Medicare payment amount
$245,992.71
Medicare beneficiaries
535
Total services
14,602
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Diabetes
55%
CMS beneficiary-panel share
Chronic kidney disease
46%
CMS beneficiary-panel share
Osteoporosis
39%
CMS beneficiary-panel share
Anxiety
35%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, denosumab, 1 mg | 4,680 | $25.64 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 500 | $125.07 |
| Injection of drug or substance under skin or into muscle | 136 | $14.02 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 113 | $34.24 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 95 | $163.38 |
| Hemoglobin a1c level | 65 | $9.52 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 43 | $127.75 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 35 | $16.37 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 33 | $77.89 |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 15 | $178.56 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1790701092. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Levothyroxine Sodium | Levothyroxine Sodium | 495 | 1,190.2 | $5,921.41 |
| 2 | Ozempic | Semaglutide | 210 | 294.9 | $271,609.70 |
| 3 | Metformin Hcl | Metformin Hcl | 149 | 354.9 | $1,307.95 |
| 4 | Metformin Hcl Er | Metformin Hcl | 132 | 324.7 | $1,545.55 |
| 5 | Glimepiride | Glimepiride | 127 | 252 | $738.84 |
| 6 | Jardiance | Empagliflozin | 121 | 191.3 | $110,525.25 |
| 7 | Trulicity | Dulaglutide | 121 | 169.7 | $162,954.63 |
| 8 | Synthroid | Levothyroxine Sodium | 117 | 216.2 | $8,158.62 |
| 9 | Novolog Flexpen | Insulin Aspart | 111 | 239.5 | $23,912.58 |
| 10 | Lantus Solostar | Insulin Glargine,Hum.Rec.Anlog | 103 | 251.7 | $10,699.82 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
1998
Group/practice field
St Lukes Physician Group Inc
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.